QUALITY OF LIFE IN PATIENTS WITH RELAPSED AND REFRACTORY MULTIPLE MYELOMA TREATED WITH THE BCMA-TARGETED CAR T CELL THERAPY IDECABTAGENE VICLEUCEL (IDE-CEL; BB2121): RESULTS FROM THE KARMMA TRIAL

EHA Library, Julia Braverman, 293491

BENEFICIAL EFFECT ON OVERALL SURVIVAL OF EARLY SALVAGE TREATMENT WITH SECOND-GENERATION NOVEL AGENTS AT BIOCHEMICAL RELAPSE: A REAL-WORLD SINGLE CENTER EXPERIENCE

EHA Library, Uros Markovic, 293492

REAL-WORLD OUTCOMES OF BELANTAMAB MAFODITIN TREATMENT FOR PATIENTS WITH RELAPSED/REFRACTORY MYELOMA VIA GSK EXPANDED ACCESS PROGRAM.

EHA Library, Tamir Shragai, 293493

DIFFUSION WEIGHTED WHOLE BODY MRI FOR EVALUATION OF RESPONSE AFTER ASCT IN MULTIPLE MYELOMA

EHA Library, Gregorio Barilà, 293494

LENALIDOMIDE AND LOW-DOSE DEXAMETHASONE (RD) AS FIRST LINE TREATMENT OF NEWLY-DIAGNOSED MULTIPLE MYELOMA PATIENTS NOT ELIGIBLE TO STEM CELL TRANSPLANTATION: REAL LIFE ITALIAN EXPERIENCE

EHA Library, ALESSANDRA POMPA, 293495

CLINICAL OUTCOMES AND HEALTH-RELATED QUALITY OF LIFE (HRQOL) AMONG RANDOMIZED CLINICAL TRIAL (RCT)-ELIGIBLE AND RCT-INELIGIBLE PATIENTS: RESULTS FROM THE CONNECT® MM REGISTRY

EHA Library, Lynne Wagner, 293496

DREAMM-2: SINGLE-AGENT BELANTAMAB MAFODOTIN (GSK2857916) IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM) AND RENAL IMPAIRMENT

EHA Library, Hans Lee, 293497

EFFICACY AND TOXICITY OF AUTOLOGOUS BLOOD STEM CELL TRANSPLANTATION IN ELDERLY MYELOMA PATIENTS

EHA Library, Sejla Hujic, 293498

TREATMENT PATTERNS OF LENALIDOMIDE DELIVERY AND OUTCOMES IN MULTIPLE MYELOMA PATIENTS IN REAL-WORLD SETTINGS: A MULTI-CENTER RETROSPECTIVE STUDY

EHA Library, Wolfgang Willenbacher, 293499

ISATUXIMAB SHORT-DURATION FIXED-VOLUME INFUSION COMBINATION THERAPY FOR RELAPSED/REFRACTORY MULTIPLE MYELOMA: FINAL RESULTS OF A PHASE 1B FEASIBILITY/SAFETY STUDY

EHA Library, Saad Z. Usmani, 293500

RESPONSE TO CARFILZOMIB REGIMENS AMONG PATIENTS WITH EARLY OR LATE RELAPSE FOLLOWING PRIOR MULTIPLE MYELOMA THERAPY: A SUBGROUP ANALYSIS FROM A PROSPECTIVE OBSERVATIONAL STUDY ACROSS EUROPE AND ISRAEL

EHA Library, Evangelos Terpos, 293501

PROGNOSTIC IMPACT OF CYTOGENETIC EVOLUTION AND ACQUISITION OF DEL(17P) IN MULTIPLE MYELOMA

EHA Library, Aleksander Salomon-Perzyński, 293502

THE PROGNOSTIC IMPACT OF 1Q21 GAIN IN NEWLY DIAGNOSED MULTIPLE MYELOMA. A MULTICENTER STUDY.

EHA Library, Rafael Rios-Tamayo, 293503

REAL WORLD EXPERIENCE OF SALVAGE 2ND AUTOGRAFT FOR RELAPSED MYELOMA: TIME TO PROGRESSION AFTER 1ST AUTOGRAFT AND CONSOLIDATION/MAINTENANCE IMPROVE PROGRESSION FREE SURVIVAL

EHA Library, Huw Richards, 293505

POMALIDOMIDE, BORTEZOMIB, DEXAMETHASONE AFTER 1 PRIOR LINE OF THERAPY IN PATIENTS WITH RELAPSED OR REFRACTORY MULTIPLE MYELOMA AND RENAL IMPAIRMENT: OPTIMISMM SUBANALYSIS

EHA Library, Fredrik Schjesvold, 293506

DREAMM-2: ASSESSING EFFICACY VIA INDIRECT COMPARISON OF SINGLE-AGENT BELANTAMAB MAFODOTIN VERSUS SELINEXOR PLUS DEXAMETHASONE COMBINATION IN ANTI-CD38 EXPOSED RELAPSED/REFRACTORY MULTIPLE MYELOMA

EHA Library, Rakesh Popat, 293507

ISATUXIMAB PLUS POMALIDOMIDE AND DEXAMETHASONE IN RELAPSED/REFRACTORY MULTIPLE MYELOMA PATIENTS WITH 1Q21 GAIN: INSIGHTS FROM PHASE 1 AND PHASE 3 STUDIES

EHA Library, PAUL RICHARDSON, 293508

THROMBOTIC MICROANGIOPATHY IN MYELOMA PATIENTS TREATED WITH FRONTLINE CARFILZOMIB ON THE PHASE 2 CARDAMON TRIAL

EHA Library, Marquita Camilleri, 293509

ORTHOTOPIC HEART TRANSPLANT FACILITATED AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION FOR LIGHT-CHAIN AMYLOIDOSIS: LONG-TERM OUTCOMES

EHA Library, Rammurti Kamble, 293510

ASSESSMENT OF DISEASE BURDEN IN TERMS OF HEALTH-RELATED QUALITY OF LIFE IN PATIENTS WITH MULTIPLE MYELOMA NOT ELIGIBLE FOR ASCT IN SPAIN: UPDATE OF THE QOLMMBUS STUDY

EHA Library, Javier De La Rubia, 293511

AMINO ACID-BASED FLUCICLOVINE PET/CT DETECTION OF MULTIPLE MYELOMA

EHA Library, Jakob Nordberg Nørgaard, 293512

POMALIDOMIDE-BASED TREATMENT IN RELAPSED REFRACTORY MULTIPLE MYELOMA: ANALYSIS BY FIRST-LINE MELPHALAN THERAPY IN A EUROPEAN POST-AUTHORIZATION SAFETY STUDY

EHA Library, Niels Abildgaard, 293513

A NATIONWIDE, POPULATION-BASED REGISTER OF SYSTEMIC AL AMYLOIDOSIS PATIENTS IN THE NETHERLANDS; PRELIMINARY RESULTS OF 205 PATIENTS DIAGNOSED IN 2017 AND 2018

EHA Library, Mirian Brink, 293514

REAL-LIFE TREATMENT OUTCOME OF FIRST-LINE REGIMEN FOR NON-TRANSPLANT ELDERLY PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA

EHA Library, Yasutaka Kakinoki, 293515

IMMUNOPARESIS AT DIAGNOSIS IS AN ADVERSE PROGNOSTIC FACTOR FOR PROGRESSION FREE-SURVIVAL AND OVERALL SURVIVAL IN MULTIPLE MYELOMA

EHA Library, Teresa Ribeiro, 293516

REAL-LIFE BORTEZOMIB MAINTENANCE PROVIDES SIMILAR OUTCOMES TO THOSE REPORTED WITH ALTERNATIVE MAINTENANCE STRATEGIES: A MULTISITE RETROSPECTIVE STUDY.

EHA Library, Efrat Luttwak, 293517

HEALTH-RELATED QUALITY OF LIFE IN HEAVILY PRE-TREATED AND RENALLY IMPAIRED PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA RECEIVING ISATUXIMAB PLUS POMALIDOMIDE AND DEXAMETHASONE: ICARIA-MM STUDY

EHA Library, Meletios Dimopoulos, 293518

HORIZON (OP-106): AN EXPLORATORY ANALYSIS OF TIME TO NEXT TREATMENT IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA WHO RECEIVED MELFLUFEN PLUS DEXAMETHASONE

EHA Library, María-Victoria Mateos, 293519

LIMITED EFFICACY OF DARATUMUMAB IN MULTIPLE MYELOMA WITH EXTRAMEDULLARY DISEASE

EHA Library, Tomas Jelinek, 293520

DREAMM-6: SAFETY AND TOLERABILITY OF BELANTAMAB MAFODOTIN IN COMBINATION WITH BORTEZOMIB/DEXAMETHASONE IN RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM)

EHA Library, Rakesh Popat, 293521

PATIENT CHARACTERISTICS, TREATMENT PATTERNS AND OUTCOMES IN PATIENTS WITH TRIPLE CLASS REFRACTORY MULTIPLE MYELOMA

EHA Library, Maneesha Mehra, 293522

A SYSTEMATIC LITERATURE REVIEW TO ASSESS EFFICACY OF TREATMENTS IN TRIPLE-CLASS EXPOSED RELAPSED AND REFRACTORY MULTIPLE MYELOMA PATIENTS

EHA Library, Faith Davies, 293523

FRONTLINE (FL) TREATMENT PATTERNS AND USE OF MAINTENANCE THERAPY (MT) IN NEWLY DIAGNOSED MULTIPLE MYELOMA (NDMM) PATIENTS NOT RECEIVING FL STEM CELL TRANSPLANT (NSCT)

EHA Library, Dasha Cherepanov, 293524

THE PERCENTAGE OF ABNORMAL PLASMA CELL AMONG TOTAL BM PLASMA CELLS PREDICTED THE DISEASE PROGRESSION AFTER MRD REAPPEARANCE IN PATIENTS WITH TRANSPLANT ELIGIBLE NEWLY DIAGNOSED MULTIPLE MYELOMA

EHA Library, Jingli Gu, 293525

IXAZOMIB REAL-LIFE-SETTING USE IN COMBINATION WITH LENALIDOMIDE AND DEXAMETHASONE IN RELAPSED OR REFRACTORY MULTIPLE MYELOMA: REMIX, A PROSPECTIVE, NON-INTERVENTIONAL STUDY

EHA Library, Lauriane Filliatre-Clément, 293526

DREAMM-2: SINGLE-AGENT BELANTAMAB MAFODOTIN (GSK2857916) IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM) AND HIGH-RISK (HR) CYTOGENETICS

EHA Library, Suzanne Trudel, 293527

CORTICOSTERIOD TAPERING IN PATIENTS WITH RELAPSED OR REFRACTORY MULTIPLE MYELOMA RECEIVING SUBCUTANEOUS DARATUMUMAB (DARA SC): PART 3 OF THE OPEN-LABEL, MULTICENTER, PHASE 1B PAVO STUDY

EHA Library, Hareth Nahi, 293528

EVOLVING OUTCOMES IN MM REAL-WORLD PRACTICE: 20-YEARS SINGLE CENTER EXPERIENCE

EHA Library, Claudia Bellofiore, 293529

PROFILE CHARACTERISTICS OF LONG-TERM SURVIVORS IN MULTIPLE MYELOMA

EHA Library, Florence Sabirou, 293530

24-H URINE: IS IT REALLY NECESSARY FOR MULTIPLE MYELOMA FOLLOW-UP?

EHA Library, Joao Pedro Barreto, 293531

HEMATOLOGIC MALIGNACIES AND GAMMOPATHIES IN GAUCHER DISEASE TYPE 1

EHA Library, Maria Domenica Cappellini, 293533

MULTIPLE MYELOMA FRAILTY POPULATION IN SPAIN: PRELIMINARY ANALYSIS OF THE INSIGHT MM REGISTRY

EHA Library, Noemi Puig, 293534

THE ORAL MICROBIOME IN PATIENTS WITH RELAPSED/REFRACTORY MYELOMA TREATED WITH IXAZOMIB-THALIDOMIDE-DEXAMETHASONE (AGMT_MM-1 PHASE II TRIAL)

EHA Library, Heinz Ludwig, 293535

SPORADIC LATE ONSET NEMALINE MYOPATHY WITH MONOCLONAL PROTEIN IS A MALIGNANCY AND SHOULD BE TREATED WITH CHEMOTHERAPY-BASED APPROACH

EHA Library, Rouslan Kotchetkov, 293536

DREAMM-2 PIVOTAL STUDY: ANALYSIS OF THE LYOPHILIZED PRESENTATION COHORT OF SINGLE-AGENT BELANTAMAB MAFODOTIN FOR RELAPSED/REFRACTORY MULTIPLE MYELOMA

EHA Library, PAUL RICHARDSON, 293537

POST-AUTHORIZATION SAFETY STUDY COMPARING LENALIDOMIDE-BASED TREATMENT VS NON−LENALIDOMIDE-BASED TREATMENT IN PATIENTS WITH TRANSPLANT-INELIGIBLE NEWLY DIAGNOSED MULTIPLE MYELOMA

EHA Library, Barbara Gamberi, 293538

A REAL-WORLD COMPARATIVE EFFECTIVENESS ANALYSIS OF PROTEASOME INHIBITOR-BASED REGIMENS IN RELAPSED/REFRACTORY MULTIPLE MYELOMA UTILIZING A NATIONWIDE DATABASE IN JAPAN

EHA Library, Hirokazu Tanaka, 293539

THE RELATIONSHIP BETWEEN NEGATIVITY OF SERUM FREE LIGHT CHAINS, MINIMAL RESIDUAL DISEASE, AND OVERALL SURVIVAL IN PATIENTS WITH SYMPTOMATIC MULTIPLE MYELOMA

EHA Library, Kentaro Narita, 293540

DOUBLE AND TRIPLE HIT MULTIPLE MYELOMA: NEW ULTRA HIGH-RISK ENTITIES?

EHA Library, Aleksandra Sretenovic, 293541

EFFECT OF PROLONGED TREATMENT WITH CARFILZOMIB, LENALIDOMIDE AND DEXAMETHASONE IN RELAPSED AND REFRACTORY MULTIPLE MYELOMA

EHA Library, Cécile Gruchet, 293542

GAIT SPEED AND HANDGRIP TEST TO ASSESS PHYSICAL FRAILTY IN PATIENTS WITH MULTIPLE MYELOMA

EHA Library, Sotirios Bristogiannis, 293543

AUTOLOGOUS STEM CELL TRANSPLANT AFTER INDUCTION THERAPY IMPROVES OUTCOME IN INITIALLY INELIGIBLE PATIENTS WITH SYSTEMIC IMMUNOGLOBULIN LIGHT CHAIN AMYLOIDOSIS

EHA Library, Ilaria Cappuccio, 293544

SURVIVAL TRENDS IN MULTIPLE MYELOMA AFTER AUTOLOGOUS HEMATOPIETIC STEM CELL TRANSPLANTATION

EHA Library, Samer A. Srour, 293545

CLINICAL PHENOTYPES AND BLOOD FEATURES ASSOCIATED WITH CLONAL MYELOPOIESIS IN THE UK BIOBANK COHORT: ASXL1 MUTATIONS ARE STRONGLY ASSOCIATED WITH SMOKING HISTORY

EHA Library, Nick Cross, 293546

EXPLOITING THE CD47-SIRPΑ MACROPHAGE CHECKPOINT TO CONTROL POLYCYTHEMIA VERA

EHA Library, Veronika Lysenko, 293547

IN SYSTEMIC MASOCYTOSIS, MIDOSTAURIN TARGETS BOTH KIT AND AURORA KINASE A REVERTING H3K36ME3 DEFICIENCY AND SYNERGIZES WITH NILOTINIB AND DASATINIB

EHA Library, Manuela Mancini, 293548

CLONAL HETEROGENEITY AND EVOLUTION OF MPN REVEALED BY SINGLE-CELL RNA/DNA SEQUENCING

EHA Library, Xingxing Qi, 293549

SETD2 PROTEIN LEVELS ARE A NOVEL PREDICTOR OF OVERALL SURVIVAL IN SYSTEMIC MASTOCYTOSIS

EHA Library, Michela Rondoni, 293550

IL-1RA LEVEL IN THE SERUM IS STRONGLY CORRELATED WITH THE JAK2V617F ALLELE BURDEN, MYELOFIBROSIS, SPLENOMEGALY AND SLAMF7HIGH CD16− MONOCYTES IN THE PATIENTS WITH MYELOPROLIFERATIVE NEOPLASMS

EHA Library, Takaaki Maekawa, 293552

HLA CLASS I GENOTYPE SHAPES JAK2 V617F DRIVEN LEUKEMOGENESIS

EHA Library, Velizar Shivarov, 293553

A NOVEL IN VITRO PLATFORM FOR THE PRIORITISATION AND VALIDATION OF INHIBITORS OF BONE MARROW FIBROSIS USING HUMAN BONE MARROW (BM) STROMAL CELLS

EHA Library, Michela Colombo, 293554

NOVEL MULTIDIMENSIONAL ANALYSIS APPROACHES TO IDENTIFY POLYCYTHEMIA VERA-SPECIFIC BIOMARKERS OF OUTCOME

EHA Library, Martina Barone, 293555

NECROPTOTIC SIGNALING IS ENHANCED IN PERIPHERAL BLOOD MONONUCLEAR CELLS (PBMC) FROM PATIENTS WITH MYELOFIBROSIS (MF)

EHA Library, Veronika Dill, 293556

HOMOZYGOUS CALRETICULIN MUTATIONS AFFECT CHAPERONE FUNCTION AND PERTURB THE GLYCOPROTEOME

EHA Library, Patrick Schürch, 293557

THE NEUTROPHIL TO LYMPHOCYTE RATIO (NLR) IS A CHEAP SURROGATE OF THE IMMUNESUPPRESSIVE MICROENVIRONMENT IN MYELOFIBROSIS AND MAY PREDICT RESPONSE TO RUXOLITINIB

EHA Library, Alessandra Romano, 293558

EXPRESSION OF CD47 AND CALR IN MYELOPROLIFERATIVE NEOPLASMS: POTENTIAL NEW THERAPEUTICAL TARGETS

EHA Library, Ciro Rinaldi, 293560

REWIRED CELL ENERGY METABOLISM IN A NOVEL KRAS-MUTATED HISTIOCYTOSIS CHARACTERIZED BY SEVERE SYNOVITIS

EHA Library, Giulio Cavalli, 293561

FREQUENCY OF BCR-ABL1, JAK2V617F, MPLW515L/K AND CALR TYPE 1,2 MUTATIONS CO-OCCURENCE IN CML PATIENTS UNDERGOING TKI THERAPY AND ITS POSSIBLE PROGNOSTIC VALUE

EHA Library, Adhamjon Abdullaev, 293562

MOLECULAR CHARACTERISATION OF THE DER(6)T(1;6) IN MYELOID NEOPLASMS

EHA Library, Sophie Laird, 293563

PHENFORMIN INCREASES THE FREQUENCIES OF LSK, MULTIPOTENT PROGENITOR, AND MYELOID PROGENITOR IN JAK2V617F MURINE MODEL OF MYELOPROLIFERATIVE NEOPLASM

EHA Library, Antonio Bruno Alves-Silva, 293564

CLINICAL AND BIOLOGICAL FEATURES DISTINGUISH MYELOID DISEASES FROM MYELOID DISORDERS ASSOCIATED WITH AUTOIMMUNE DISEASES.

EHA Library, sara galimberti, 293565

CLINICAL SIGNIFICANCE OF MPL MUTATIONS IN ESSENTIAL THROMBOCYTEMIA PATIENTS: RISK ASSESMENT OF MYELOFIBROTIC TRANSFORMATION.

EHA Library, Rocío García-Serra, 293566

ROLE OF TRAINED IMMUNITY AND IMMUNOMETABOLISM IN THE PATHOGENESIS OF ERDHEIM-CHESTER DISEASE

EHA Library, Giulio Cavalli, 293567

AVAPRITINIB INDUCES RESPONSES IN PATIENTS (PTS) WITH ADVANCED SYSTEMIC MASTOCYTOSIS (ADVSM), REGARDLESS OF PRIOR MIDOSTAURIN THERAPY

EHA Library, Jason Gotlib, 293568

A PHASE 2 STUDY OF BOMEDEMSTAT (IMG-7289), A LYSINE-SPECIFIC DEMETHYLASE-! (LSD!) INHIBITOR, FOR THE TREATMENT OF LATER-STAGE MYELOFIBROSIS (MF)

EHA Library, Kristen Pettit, 293569

NAVITOCLAX IN COMBINATION WITH RUXOLITINIB IN PATIENTS WITH PRIMARY OR SECONDARY MYELOFIBROSIS: A PHASE 2 STUDY

EHA Library, Claire Harrison, 293570

RESULTS FROM PIONEER: A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PHASE 2 STUDY OF AVAPRITINIB IN PATIENTS WITH INDOLENT SYSTEMIC MASTOCYTOSIS

EHA Library, Cem Akin, 293571

CPI-0610, BROMODOMAIN AND EXTRATERMINAL DOMAIN PROTEIN (BET) INHIBITOR, AS 'ADD-ON' TO RUXOLITINIB (RUX), IN ADVANCED MYELOFIBROSIS PATIENTS WITH SUBOPTIMAL RESPONSE: UPDATE OF MANIFEST PHASE 2 STUDY

EHA Library, Srdan Verstovsek, 293572

CPI-0610, A BROMODOMAIN AND EXTRATERMINAL DOMAIN PROTEIN (BET) INHIBITOR, IN COMBINATION WITH RUXOLITINIB, IN JAK INHIBITOR TREATMENT NAÏVE MYELOFIBROSIS PATIENTS: UPDATE FROM MANIFEST PHASE 2 STUDY

EHA Library, John Mascarenhas, 293573

ROPEGINTERFERON ALPHA-2B IS EFFICACIOUS AND REDUCES VARIANT TET2 ALLELE BURDEN IN PATIENTS WITH POLYCYTHAEMIA VERA AND TET2 MUTATION: GENETIC ANALYSIS OF PHASE III PROUD-PV/CONTINUATION-PV STUDIES

EHA Library, Robert Kralovics, 293574

RUTINE USE OF GERIATRIC ASSESSMENT TOOLS AMONG URUGUAYAN HAEMATOLOGISTS

EHA Library, Gimena dos Santos, 298394

DIFFERENT FACTORS DICTATE MENTAL COPING STRATEGIES OF PATIENTS WITH ACUTE MYELOID LEUKEMIA AT DIFFERENT TIME-POINTS

EHA Library, Oren Pasvolsky, 298395

CLINICAL EXPERIENCE AND OPTIMIZATION OF THE MANAGEMENT OF SECONDARY IMMUNODEFICIENCY IN HEMATOLOGICAL MALIGNANCY

EHA Library, Silvia Sánchez-Ramon, 298396

SUPPORTING CLINICIANS IN PROVIDING THE BEST CARE FOR MYELOMA PATIENTS AND FACILITATING TIMELY DIAGNOSIS TO IMPROVE SURVIVAL AND QUALITY OF LIFE

EHA Library, Ira Laketic-Ljubojevic, 298397

HIGH PREVALENCE OF METABOLIC, ENDOCRINE AND BONE DISEASE IN HISPANIC SURVIVORS OF ACUTE LEUKEMIA

EHA Library, Alfonso Orozco Collazo, 298398

ASSESSMENT OF BOTH COMPARATIVE AND COST EFFECTIVENESS OF CAR-T TREATMENTS IN TREATING DLBCL BY HARNESSING REAL WORLD EVIDENCE

EHA Library, Duane Schulthess, 298399

EFFICACY OF IMPAIRMENT-BASED MANUAL PHYSICAL THERAPY IN TREATMENT OF HEMOPHILIC ANKLE ARTHROPATHY- A SINGLE-GROUP SINGLE SUBJECT EXPERIMENTAL STUDY

EHA Library, Senthil Kumar Paramasivam, 298400

IMMUNOGLOBULIN REPLACEMENT THERAPY AS A SUPPORTIVE CARE IN ADULT HEMATOLOGICAL PATIENTS: A PROSPECTIVE STUDY

EHA Library, Olga Gerasimovich, 298401

TYPE OF VENTILATORY SUPPORT AS AN INDEPENDENT PROGNOSTIC FACTOR IN CRITICALLY ILL HEMATOLOGIC MALIGNANCIES PATIENTS

EHA Library, Ana Oliver, 298402

COMPARISON OF FOUR AUTOMATED HEMATOLOGY ANALYZERS; BECKMAN COULTER DXH 900, SYSMEX XP-300, ABBOTT CELL-DYN EMERALD AND HORIBA ABX PENTRA

EHA Library, Hyunji Choi, 298403

THE INFORMATION SEEKING BEHAVIOURS OF MYELOMA PATIENTS AND CARERS WHILST ENGAGING WITH THE MYELOMA UK INFOLINE HELPLINE AND THE ASK THE NURSE EMAIL SERVICES

EHA Library, Sandra Quinn, 298404

LIFE OF CENTRAL VENOUS ACCESS DEVICE (CVAD) IN PATIENTS WITH HEMATOLOGIC DISORDERS – EXPERIENCE OF A SINGLE TERTIARY CARE CENTRE IN INDIA

EHA Library, Revanth Boddu, 298405

PAST, PRESENT, FUTURE – THE ROLE OF EXTERNAL QUALITY ASSESSMENT PARTICIPATION IN ASSURING THE ACCURACY OF GENOMIC TESTING IN HAEMATOLOGICAL NEOPLASMS

EHA Library, Katrina Rack, 298406

EXTENT OF HEMOGLOBIN GLYCATION ON THE BRINK BETWEEN HEMATOLOGY AND DIABETOLOGY

EHA Library, Urs Nydegger, 298407

ESTABLISHMENT REFERENCE INTERVALS IN MALAYSIA : A PERFORMANCE EVALUATION AND COMPARISON OF HAEMATOLOGICAL PARAMETERS BETWEEN SYSMEX XE5000 AND XN3000

EHA Library, Siew Lian Chong, 298408

WHAT ARE THE CHALLENGES FOR BUILDING REAL WORLD COMPARATIVE COHORTS IN HAEMATOLOGY?

EHA Library, Nikita Jeswani, 298409

DIAGNOSIS OF ACUTE LEUKEMIA AND ITS IMPACT IN A RESOURCE POOR CENTRE OF EASTERN INDIA: A RETROSPECTIVE OVERVIEW

EHA Library, Debmalya Bhattacharyya, 298410

COST-EFFECTIVENESS OF REFERRALS TO SECONDARY CARE FOR ELEVATED SERUM VITAMIN B12

EHA Library, Dipal Mehta, 298411

RELATIVE FINANCIAL IMPLICATIONS OF HEMATOPOIETIC STEM CELL TRANSPLANTATION IN DEVELOPING AND THE DEVELOPED WORLD

EHA Library, Santanu Sen, 298412

PHASE 3, RANDOMIZED, OPEN-LABEL STUDY OF PEMBROLIZUMAB (PEMBRO) VERSUS BRENTUXIMAB VEDOTIN (BV) FOR TREATMENT OF RELAPSED OR REFRACTORY CLASSICAL HODGKIN LYMPHOMA (R/R CHL): KEYNOTE-204

EHA Library, Pier Luigi Zinzani, 303389